Influenza Vaccination: Clinical Trials

2 trials for Influenza Vaccination, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 31Recruiting 1

Follow Influenza Vaccination: new trials by email Literature Review of Influenza Vaccination trials Research Report on Influenza Vaccination

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Evaluate the Immunogenicity and Safety of GC3114B in Adults Aged 65 Years or Older
vaccination of GC3114B, Vaccination of Efluelda - Influenza A, Influenza B, Influenza Vaccination
Phase 2 / Phase 3RecruitingGC Biopharma Corp18062026-10-122026-11-18
Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.
Lactobacillus coryniformis K8 CECT5711, Control placebo - Influenza Vaccination, Immune Response
Phase 2CompletedBiosearch S.A.982015-10-012017-05-30

Narrower conditions

Influenza, Human (2)

Broader conditions

Infections (2)  ·  Orthomyxoviridae Infections (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)

Sponsors

Biosearch S.A. (1)  ·  GC Biopharma Corp (1)

Countries

South Korea (1)